Keebeck Wealth Management, LLC

SEC CIK: 0001803675
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

GYRE holding history

Gyre Therapeutics, Inc. in every 13F filed by Keebeck Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GYRE overview All 13F holders of GYRE Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2022

Holdings of GYRE by Keebeck Wealth Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−20,000−100.0%	Sold out	Holders
Q2 2023	20,000	$7.03K	<0.1%	00.0%	Unchanged	Holders
Q1 2023	20,000	$4.14K	<0.1%	00.0%	Unchanged	Holders
Q4 2022	20,000	$10.6K	<0.1%	+20,000	New	Holders